| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |